Dawn Health and Novartis Collaborate to Launch Cora BC for Breast Cancer Patients
In a moment that can transform lives, a breast cancer diagnosis often leaves individuals grappling with the abrupt halt of their daily routines and the daunting treatment process ahead. Navigating through complex therapies, managing side effects, and maintaining communication with healthcare professionals are challenges that patients encounter nearly every day. Recognizing these hurdles, Dawn Health, in collaboration with Novartis, has launched the groundbreaking app, Cora BC. This innovative tool aims to provide comprehensive support for breast cancer patients and their families, irrespective of the stage of the disease or type of treatment they are undergoing.
Cora BC empowers patients by offering them tools to monitor their health status, providing clarity and insight throughout their journey. Regular health checks and visual progress tracking through intuitive graphs help users better understand their experiences and regain a semblance of control. The app is designed to send personalized medication reminders and appointment notifications, encouraging patients to cultivate and maintain vital routines that help them navigate lengthy treatment regimens effectively.
Understanding that no two treatments or patients are identical, Cora BC personalizes its content to cater to the unique needs and experiences of each user. It addresses common concerns, offering actionable advice and meaningful information. Beyond merely serving as an informational resource, Cora BC assists users in organizing their health care by allowing diary entries and equipping them to prepare for consultations, fostering more productive and informed discussions with their medical teams.
Alexander Mandix Hansen, CEO of Dawn Health, emphasizes that "Cora BC is not just a tool; it represents a step towards enhanced care. Through our partnership with Novartis, we ensure that breast cancer patients have access to the resources and support they need to feel seen and heard, ultimately leading to better outcomes. The app mirrors our shared commitment to innovation and patient-centered care."
Initially, Cora BC will be launched in Germany, with plans to soon extend to the UK, Canada, Australia, and other markets. The app provides an easily accessible and highly beneficial solution for many patients. While it is not intended to dispense medical advice, diagnoses, or treatment recommendations, it serves as a powerful organizational resource, strengthening communication between patients, doctors, and nursing staff.
The introduction of Cora BC builds upon the successful collaboration between Dawn Health and Novartis following the development of Ekiva MS and Ekiva PNH, underscoring the potential of digital health to significantly improve the care of individuals suffering from chronic conditions. For more information about Cora BC, interested individuals can visit www.cora-bc.com.
About Dawn Health:
Dawn Health is a global leader in digital health, focusing on the development of software as a medical device (SaMD) and digital therapeutics (DTx). The Dawn Health product platform accelerates the market launch of digital solutions, driving innovation to positively impact the lives of individuals with chronic illnesses. Through close partnerships with the life sciences industry, Dawn Health creates digital health products that transform patient care with an empathetic, human-centered approach.
Cora BC empowers patients by offering them tools to monitor their health status, providing clarity and insight throughout their journey. Regular health checks and visual progress tracking through intuitive graphs help users better understand their experiences and regain a semblance of control. The app is designed to send personalized medication reminders and appointment notifications, encouraging patients to cultivate and maintain vital routines that help them navigate lengthy treatment regimens effectively.
Understanding that no two treatments or patients are identical, Cora BC personalizes its content to cater to the unique needs and experiences of each user. It addresses common concerns, offering actionable advice and meaningful information. Beyond merely serving as an informational resource, Cora BC assists users in organizing their health care by allowing diary entries and equipping them to prepare for consultations, fostering more productive and informed discussions with their medical teams.
Alexander Mandix Hansen, CEO of Dawn Health, emphasizes that "Cora BC is not just a tool; it represents a step towards enhanced care. Through our partnership with Novartis, we ensure that breast cancer patients have access to the resources and support they need to feel seen and heard, ultimately leading to better outcomes. The app mirrors our shared commitment to innovation and patient-centered care."
Initially, Cora BC will be launched in Germany, with plans to soon extend to the UK, Canada, Australia, and other markets. The app provides an easily accessible and highly beneficial solution for many patients. While it is not intended to dispense medical advice, diagnoses, or treatment recommendations, it serves as a powerful organizational resource, strengthening communication between patients, doctors, and nursing staff.
The introduction of Cora BC builds upon the successful collaboration between Dawn Health and Novartis following the development of Ekiva MS and Ekiva PNH, underscoring the potential of digital health to significantly improve the care of individuals suffering from chronic conditions. For more information about Cora BC, interested individuals can visit www.cora-bc.com.
About Dawn Health:
Dawn Health is a global leader in digital health, focusing on the development of software as a medical device (SaMD) and digital therapeutics (DTx). The Dawn Health product platform accelerates the market launch of digital solutions, driving innovation to positively impact the lives of individuals with chronic illnesses. Through close partnerships with the life sciences industry, Dawn Health creates digital health products that transform patient care with an empathetic, human-centered approach.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.